Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 22,288 | 32,614 | 37,064 | 50,188 | 37,482 |
| Operating Income | -22,288 | -32,614 | -37,064 | -50,188 | -37,482 |
| Interest Expense | 32 | 90 | 144 | 219 | 670 |
| Other Income | 1,235 | 2,547 | 3,107 | 1,819 | 1,358 |
| Pre-tax Income | -21,085 | -30,157 | -34,101 | -48,588 | -36,794 |
| Net Income Continuous | -21,085 | -30,157 | -34,101 | -48,588 | -36,794 |
| Net Income | $-21,085 | $-30,157 | $-34,101 | $-48,588 | $-36,794 |
| EPS Basic Total Ops | -16.72 | -24.01 | -24.40 | -31.60 | -26.60 |
| EPS Basic Continuous Ops | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 |
| EPS Diluted Total Ops | -16.72 | -24.01 | -24.40 | -31.60 | -26.60 |
| EPS Diluted Continuous Ops | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 |
| EPS Diluted Before Non-Recurring Items | N/A | -23.20 | -24.40 | -31.60 | -26.60 |
| EBITDA(a) | $-22,149 | $-31,292 | $-35,713 | $-48,841 | $-36,797 |